RESUMO
A 64-year-old male patient with liver cirrhosis underwent a CT study for hepatocellular carcinoma surveillance, which demonstrated a 1.4-cm hypervascular subcapsular tumor in the liver. On gadoxetic acid-enhanced MRI, the tumor showed brisk arterial enhancement and persistent hyperenhancement in the portal phase, but hypointensity in the hepatobiliary phase. On diffusion-weighted MRI, the tumor showed an apparent diffusion coefficient twofold greater than that of the background liver parenchyma, which suggested that the lesion was benign. The histologic diagnosis was intrahepatic bile duct adenoma with alcoholic liver cirrhosis.
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Adenoma de Ducto Biliar/diagnóstico , Neoplasias dos Ductos Biliares/diagnóstico , Ductos Biliares Intra-Hepáticos , Meios de Contraste , Diagnóstico Diferencial , Imagem de Difusão por Ressonância Magnética/métodos , Gadolínio DTPA , Cirrose Hepática/complicaçõesRESUMO
El hamartoma peribiliar (HPB) o adenoma de conductos biliares corresponde a un tumor hepático benigno, que representa tan solo el 1,3 por ciento de todos los tumores primarios del hígado. Macroscópicamente corresponde a una lesión redondeada bien delimitada, subcapsular, siendo habitualmente diagnosticado como un hallazgo intra-operatorio o de autopsia. Se presentan dos pacientes con diagnóstico incidental de HPB realizado en la Unidad de Anatomía Patológica del Hospital Hernán Henríquez de Temuco.
Peribiliary gland hamartoma (PGH) or bile duct adenoma corresponds to a benign liver tumor, which represents only 1.3 percent of all primary liver tumors. Corresponds to a macroscopically well-defined round lesion, subcapsular, and is usually diagnosed as an intra-operative findings or autopsy. We report two patients with incidental diagnosis of PGH conducted in the Pathology Unit of the Hospital Hernán Henríquez in Temuco.